discovered that ADAR1 can results in the progression of Diffuse Large B‐Cell Lymphoma (DLBCL) via A‐to‐I editing of mitochondrial antiviral signalling (MAVS) transcripts, the downstream adaptor of the RLR.161. The gene discussed is MAVS; the disease is diffuse large B-cell lymphoma.